New Key Statistics Module, Z-Score and F-Score
HKSE:09966 Key Ratios
Market Cap HK$ M | 4,279.28 |
Enterprise Value HK$ M | 2,747.55 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.45 |
Price/Sales | 15.43 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 276.00 |
EPS (TTM) HK$ | -0.25 |
Beneish M-Score | -2.47 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 19.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -12.30 |
EV-to-EBITDA | -19.21 |
PEG | -- |
Shares Outstanding M | 961.64 |
Net Margin (%) | -84.90 |
Operating Margin % | -103.47 |
Pre-tax Margin (%) | -84.90 |
Quick Ratio | 4.42 |
Current Ratio | 4.61 |
ROA % (ttm) | -9.81 |
ROE % (ttm) | -12.59 |
ROIC % (ttm) | -32.13 |
Dividend Yield % | -- |
Altman Z-Score | 3.67 |
HKSE:09966 Number of Guru Trades
HKSE:09966 Volume of Guru Trades
Gurus Latest Trades with HKSE:09966
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:09966 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Alphamab Oncology Insider Transactions
No Available Data